Bioprinting: From Research to Clinical and Industrial Translation

Bioprinting: From Research to Clinical and Industrial Translation

Bioprinting is emerging as a key enabling technology in regenerative medicine and personalized healthcare. This session provides an overview of the latest processes, methods, and technological advances in 3D bioprinting, with a strong link between research, clinical application, and industrial implementation.

A particular focus lies on how bioprinting can help address the growing shortage of donor organs by enabling patient-specific tissues, implants, and regenerative solutions, reducing dependence on transplantation and long-term immunosuppression.

Key Topics:

• Bioprinting of living cells for regenerative medicine
• Patient‑specific implants and tissue repair
• Translation from lab to clinic and industry
• International research and industrial collaboration
• The role of the Netherlands in the European bioprinting ecosystem
• Alignment with Horizon Europe Cluster Health and future funding opportunities

Program:

• 2:00 PM – 2:05 PM – Introduction, welcome and outline of the program
• 14:05-14:25 – Bone marrow engineering & mimicking – Cornelia Lee-Thedieck
• 14:25-14:45 – 3D Bioprinting: from the lab to translational applications – Monize Caiado Decarli
• 14:45-15:05 – 3D Bioprinting the Heart: From Engineered Tissues to Regenerative Therapies – Joost Sluijter
• 15:05-15:10: Bridge to pitches: Short introduction to the pitch format
• 15:10-15:15: Pitch 1: Bioprinting & AI – Riccardo Levato
• 15:15-15:20: Pitch 2: An integral approach to replace animal-derived products in cell culture – Melissa van Velthoven
• 15:20-15:30: Pitch 3:Bridging Innovation and Healthcare – Joost van Duijn

Co-organizers: Jutta Wirth, Wageningen University & Research; Edwin Roovers, High Tech NL Life Sciences and Zerafet Tenwolde, Z3Dlabs.